ERCC3 and cancer: Thus, DNA repair helicases expressed highly in most malignant and rapidly proliferating cancer cells not only provide new proliferative protein markers, such as WRN and RECQL1 proteins (Figure 2), but also provide logical consequences for combination therapy to fight against drug-resistant cancer cells.